Thus, it is not surprising that CDKN2AIP represents a potential therapeutic target for cancer treatments (Kalra et al. 2018) and is suggested to be an important factor in the ageing process (Cheung et al. 2010). The gene discussed is CDKN2AIP; the disease is cancer.